| Primary |
| Respiratory Tract Infection Bacterial |
69.7% |
| Sinusitis |
8.2% |
| Bronchitis |
5.8% |
| Pneumonia |
4.7% |
| Upper Respiratory Tract Infection |
2.3% |
| Respiratory Tract Infection |
1.2% |
| Cough |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Product Used For Unknown Indication |
0.8% |
| Bronchitis Acute |
0.7% |
| Bronchitis Chronic |
0.7% |
| Pulmonary Congestion |
0.7% |
| Rhinitis |
0.7% |
| Ear Infection |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Lower Respiratory Tract Infection |
0.5% |
| Tympanic Membrane Perforation |
0.5% |
| Bronchopneumonia |
0.3% |
| Cellulitis |
0.3% |
| Influenza |
0.3% |
|
| Rash |
39.2% |
| Rash Generalised |
21.5% |
| Urticaria |
5.9% |
| Rash Maculo-papular |
3.6% |
| Rash Pruritic |
2.8% |
| Swelling Face |
2.8% |
| Vomiting |
2.8% |
| Drug Ineffective |
2.6% |
| Rash Papular |
2.3% |
| Diarrhoea |
2.1% |
| Urticaria Generalised |
2.1% |
| Stevens-johnson Syndrome |
1.8% |
| Hallucination |
1.5% |
| Vision Blurred |
1.5% |
| White Blood Cell Count Increased |
1.5% |
| Clostridium Colitis |
1.3% |
| Rash Erythematous |
1.3% |
| Rash Macular |
1.3% |
| Headache |
1.0% |
| Nausea |
1.0% |
|
| Secondary |
| Product Used For Unknown Indication |
14.7% |
| Sinusitis |
12.0% |
| Bronchitis |
8.0% |
| Cough |
8.0% |
| Smoking Cessation Therapy |
6.7% |
| Bronchitis Chronic |
5.3% |
| Convulsion |
5.3% |
| Infection |
5.3% |
| Pneumonia |
5.3% |
| Clostridium Difficile Colitis |
4.0% |
| Tympanic Membrane Perforation |
4.0% |
| Cystopexy |
2.7% |
| Diabetes Mellitus |
2.7% |
| Dyspnoea |
2.7% |
| Hysterectomy |
2.7% |
| Influenza |
2.7% |
| Nasopharyngitis |
2.7% |
| Urinary Tract Infection |
2.7% |
| Anxiety |
1.3% |
| Arthralgia |
1.3% |
|
| Rash |
13.8% |
| Restlessness |
10.3% |
| Drug Administration Error |
6.9% |
| Therapeutic Response Delayed |
6.9% |
| Toxic Skin Eruption |
6.9% |
| Weight Bearing Difficulty |
6.9% |
| Adverse Drug Reaction |
3.4% |
| Dehydration |
3.4% |
| Dysphagia |
3.4% |
| Eczema Eyelids |
3.4% |
| Hypoglycaemia |
3.4% |
| Pain In Extremity |
3.4% |
| Pharmaceutical Product Complaint |
3.4% |
| Product Quality Issue |
3.4% |
| Pruritus |
3.4% |
| Rash Generalised |
3.4% |
| Syncope |
3.4% |
| Tendon Pain |
3.4% |
| Therapeutic Reaction Time Decreased |
3.4% |
| Vomiting |
3.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.7% |
| Respiratory Tract Infection |
13.5% |
| Cough |
8.1% |
| Pain |
8.1% |
| Female Sterilisation |
5.4% |
| Epilepsy |
4.1% |
| Pulmonary Arterial Hypertension |
4.1% |
| Sinusitis |
4.1% |
| Asthma |
2.7% |
| Back Pain |
2.7% |
| Contraception |
2.7% |
| Hypersensitivity |
2.7% |
| Influenza |
2.7% |
| Blood Pressure Abnormal |
1.4% |
| Diabetes Mellitus Non-insulin-dependent |
1.4% |
| Emphysema |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Insomnia |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Pyrexia |
1.4% |
|
| Pancreatitis Chronic |
17.4% |
| Wound Secretion |
13.0% |
| Visual Field Defect |
10.9% |
| Vomiting |
8.7% |
| Anxiety |
6.5% |
| Drug Hypersensitivity |
4.3% |
| Pain |
4.3% |
| Pyrexia |
4.3% |
| Renal Impairment |
4.3% |
| Weight Decreased |
4.3% |
| Bronchitis |
2.2% |
| Bronchospasm |
2.2% |
| Dehydration |
2.2% |
| Drug Toxicity |
2.2% |
| Hypersensitivity |
2.2% |
| Hypertension |
2.2% |
| Hypotension |
2.2% |
| Local Swelling |
2.2% |
| Muscle Spasms |
2.2% |
| Oedema Peripheral |
2.2% |
|
